key: cord-0766157-rsy6c2y4
authors: Remington, Jacob M.; McKay, Kyle T.; Ferrell, Jonathon B.; Schneebeli, Severin T.; Li, Jianing
title: Enhanced Sampling Protocol to Elucidate Fusion Peptide Opening of SARS-CoV-2 Spike Protein
date: 2021-06-02
journal: Biophys J
DOI: 10.1016/j.bpj.2021.05.022
sha: e34e94825191ae749a46872a263b5adfe2670233
doc_id: 766157
cord_uid: rsy6c2y4

Large-scale conformational transitions in the spike protein S2 domain are required during host cell infection of the SARS-CoV-2 virus. Although conventional molecular dynamics simulations have been extensively used to study therapeutic targets of SARS-CoV-2, it is still challenging to gain molecular insight into the key conformational changes due to the size of the spike protein and the long timescale required to capture these transitions. In this work, we have developed an efficient simulation protocol that leverages many short simulations, a novel selection algorithm, and Markov state models to interrogate the dynamics of the S2 domain. We discovered that the conformational flexibility of the dynamic region upstream of the fusion peptide in S2 is coupled to the proteolytic cleavage state of the spike protein. These results suggest that opening of the fusion peptide likely occurs on a sub-microsecond timescale following cleavage at the S2’ site. Building on the structural and dynamical information gained to date about S2 domain dynamics, we provide proof-of-principle that a small molecule bound to a seam neighboring the fusion peptide can slow the opening of the fusion peptide, leading to a new inhibition strategy for experiments to confirm. In aggregate, these results will aid the development of drug cocktails to inhibit infections caused by SARS-CoV-2 and other coronaviruses.

homo-trimer based on the cryo-EM (PDBID: 6VSB) were built using CHARMM-GUI (47). Only the S2 domain 3 (residues: 705-1146), which corresponds to cleavage near the S1/S2 site (8), was included in the S1/S2 cleavage 4 model. Since these models did not include the viral envelope anchored domains of the spike protein, a membrane 5 was not included in the simulations. For the S2' cleavage model residues 816 -1146 were used. Missing residues in was then performed to equilibrate the temperature to 310 K with fixed volume and the same positional restraints.

Constant temperature was achieved using a Langevin thermostat with a time-constant of 1 ps (57). A 1-ns simulation 24 to equilibrate the pressure was then run with a 4-fs timestep and the Monte Carlo barostat. A cut-off for non-bonded 25 interactions of 12 Å was used with a force-based switching at 10 Å. All production simulations were performed with 26 the same parameters as the last equilibration stage using AMBER18 (58) on a single node containing eight NVIDIA 27 telsa-V100 GPUs. 

The coordinates of these rare structures are then used to start new short simulations with randomized velocities 34 selected from a Boltzmann distribution. Repeating this process has been shown to enhance conformational sampling, 

Here, enhanced conformational sampling was achieved along the first four principal components (PC) (62) of a large but here we used the PC of the COM distances as a method for collective variable determination (63-68).

3 Accordingly, at each stage of nt-PaCS-MD, eight 1-ns length simulations (with parameters described in the Molecular 4 dynamics simulation parameters section) were performed in parallel. Then PC analysis was performed on the 5 concatenated 8-ns worth of distances in-order to determine which linear combination of the input distances 6 underwent the most conformational fluctuations, (i.e. had the greatest variance). It was our hypothesis that motion 7 along these loose degrees-of-freedom could represent initial steps in the CoVS pre-to-post fusion transition. Based 8 on this hypothesis 8 frames which maximized/minimized the first 4 principal components were used to initiate new 9 simulations. This process was repeated 200 times for each system, resulting in 1.6 µs of aggregate simulation time per system. In addition to the nt-PaCS-MD simulations, 400 further 1-ns trajectories starting from structures identified 11 by uniform space clustering of the nt-PaCS-MD trajectories were performed. Structures were saved every 20 ps.

Replica simulations were performed using the same initial structures from minimization, but different initial velocities 13 for equilibration. For ligand-bound simulations, docking of asiaticoside was performed using Glide (Schrödinger, Inc.) 14 to determine the optimal binding motif to each chain in the initial structure for MD simulation (see section, High-15 throughput screening and ensemble docking). Otherwise, MD simulations were performed identically to those 16 described in the ligand-free simulations.

Analysis of nt-PACS-MD simulations to estimate dynamics of the conformational ensemble. To begin analyzing the 19 simulations, the set of 75 center of mass distances used in the nt-PaCS-MD simulations were calculated using Pytraj.

Despite the ability of PC to interrogate the fluctuations within a conformational ensemble, it can be suboptimal for variational approach to Markov processes (VAMP) (71, 72) was used within Pyemma (67). In simplified terms, the 23 VAMP establishes a linear combination of input collective variables that optimally capture the slowest memoryless 24 processes in the dynamical system (72). Like MSMs, VAMP coordinates also utilize a lag time (VAMP lag time 

For MSM estimation, the first two VAMP coordinates with a VAMP lag time of 980 ps, were chosen as a CV 32 space and clustered using regular space cluster to get 200 cluster centers. Because the structure of the CV space 33 was different for each simulation, the minimum distance parameter in the regular space clustering algorithm was 34 optimized iteratively to achieve 200 cluster centers with a tolerance of 1 cluster center. Implied timescales (73) from 35 the totality of simulations demonstrate independence of the predicted MSM timescales on MSM lag times larger than 36 500 ps (Fig. S4 ). Using a 650-ps MSM lag time, reversible 200 state MSMs were then estimated for each system helicity of the three states in the S1/S2 model were calculated by counting the number of turns using Pymol's internal 10 secondary structure assignment.

For the ligand-bound simulations, the center of mass distance between the fusion peptide and the ligand 

Virtual screening and ensemble docking to block the pre-to-post fusion transitions. An advantage of targeting the 24 initial opening of the fusion peptide is that the more stable conformational ensemble of the nonproteolytically cleaved

CoVS containing both the S1 and S2 domains can be used to obtain characteristic structures for the pockets. For the 26 active sites 2 and 3, whose location is described in the following paragraph, the extensive sampling provided by two 

However, the long simulations did not include the aforementioned dynamic loop and were not appropriate for use in 32 the docking to site 1. For active site 1, the initial model for the S2' simulations described in the Model preparation 33 section was used because it did include the dynamic loop.

Besides the site 1 described in the results and discussion, two additional sites were chosen for docking to 35 (see Fig. 5 and S13-15). These sites were chosen by inspecting the differences between the inter-residue contacts of 36 the pre-fusion and post-fusion spike protein conformations. Locations where residues that were close in the pre-37 fusion state became far apart in the post-fusion state were found. An additional constraint was that these sites be 38 exposed to the solvent in the full spike protein model (containing both S1 and S2 domains). Finally, concave pockets 39 that were large enough to fit a small molecule led to the discovery of sites 1-3. Site 2 is composed of a kink in the small molecule that could bridge the helix and beta sheet in either these sites could slow or inhibit the spike protein 3 transition. As the SARS-CoV-2 spike glycoprotein is a homotrimer (with all three sites present on each monomer, Fig.   4 5) and the following PC analysis is time independent, each monomer of each trajectory was considered its own 5 simulation for the conformational analysis. In this way, 60 microseconds of simulation data were analyzed per active 6 sites 2 and 3 to determine characteristic structures of the targeted pockets.

Visual molecular dynamics (VMD) (77) was used to align the S2 helical domain of the protein to the initial 8 coordinates (crystal structure from PDB) to reduce noise due to translational movement. The XYZ coordinates of the 9 residues comprising active site 2 (residues 721 to 729, residues 930 to 950, and residue 1028) and active site 3 10 (residues 714 to 718, residues 914 to 925, residues 1108 to 1113, and residues 1148-1149) were collected and 11 parsed using TCL and python. A dimension reduction (PC analysis) was used to determine which residue movements 12 contributed most to variations in the overall conformations of each active site. For each active site, the first ten 13 dimensions (accounting for approximately 90% of the cumulative variance) were clustered using a K-means 14 clustering algorithm (Fig. S16 ).

Each cluster center represents a unique active-site conformation in the overall conformational ensemble. As 16 these cluster centers don't represent frames but instead are points in the principal component space, an N-17 dimensional root-mean-square deviation (RMSD) was used to find representative frames closest in value to these 18 cluster centers. These frames were then prepared using Maestro protein preparation utility and the docking grids 

Results and Discussion.

As a first step to determine the conformational dynamics of CoVS that initiate the pre-to-post fusion transition 31 (steps (3)-(4) in Fig. 1A) , we performed extensive MD simulations of the S2 domain. Specifically, we focused on two 32 all-atom models of CoVS with proteolytic cleavages of all three monomers at the S1/S2 or S2' sites respectively (the 33 S1/S2 cleavage model contains residues 705-1146, and the S2' cleavage model contains residues 816-1146) (79),

corresponding to a CoVS state just after S1 dissociation and ready to begin S2 opening and refolding (steps (3)-(4) in 35 Fig. 1 ). While there are many more possible combinations of initial models due to the presence of three monomers 36 with two cleavage sites each, we chose our models to represent two extreme cases where all the monomers are 37 cleaved at either the S1/S2 site or the S2' site. These simulations, with 2 replicas per system totaling 8 µs, were is in the conformational heterogeneity of CoVS ( Fig. S2 and S3 ). The root mean squared deviation (RMSD) relative to 3 the initial structure for 10 representative structures is much larger for the S2' cleavage model (5.4 -10.9 Å) than for 4 the S1/S2 cleavage model (3.5 -5.8 Å). This suggests that the loss of residues 705-815 between the S1/S2 sites and with extended FP than the S1/S2 simulations, suggesting that this model is more primed than the S1/S2 cleavage 7 model for FP insertion and the subsequent large-scale conformational transitions that initiate the pre-to-post fusion 8 transition.

Then we constructed reversible MSMs, to more concretely examine the conformational transitions and 10 energetics. For each system, the FES along the two slowest VAMP coordinates (71, 72), v1 and v2, were obtained 11 (see additional details in the methods). The FESs for both systems (Fig. 3 and S5 ) are characterized by broad 12 regions of low relative free energy (E < 4 kT) inhabiting two (for S1/S2) or three (for S2') long valleys. In the low 13 energy regions, three local minima are apparent in each system denoted as states A, B, and C for S1/S2 (Fig. 3) and

A', B', and C' for S2' (Fig. 3) . In a self-consistent manner, these three states also correspond to states with maximum 

Focusing on the S1/S2 cleavage model first, the three states correspond to the different degrees of displacement 29 and helicity of the region just after the fusion peptide with helicity ranked roughly from 0, 2.5, to 3.5 helical turns for 30 states B, C, and A. Based on the MFPT from B to A and C (120 and 65 ns) compared to the reverse processes (280 31 and 250 ns) and the lower relative energy (~1 kT) of the helical A/C regions, the more helical states A and C are 32 favored. For the replica simulation of the S1/S2 cleavage model, the non-helical conformational of the dynamic region 33 (state B) was not resolved by the MSM (Fig. S5 ), but the more helical state still appeared more favorable. Generally,

and more importantly, however, the dynamics of this region in the S1/S2 system are confined and do not correspond 

In contrast to the S1/S2 cleavage model, the S2' cleavage model captured large-scale displacements of residues 39 including the fusion peptide (Fig. 3, 

The dynamic opening of the fusion peptide observed in the MD simulations presents a target for small-molecule 8 inhibitors. Specifically, the observed dynamics are in general agreement with the proposed mechanism for spike 9 protein action (initiation of step 3 in Fig. 1A ). This suggests that hindering this opening event with small molecules 10 bound to specific sites on CoVS could slow down the infection process. The opening occurs at the interface between 11 the FP and the HR1 domains. Towards achieving this task, high-throughput virtual screening (HTVS) was used to find 12 molecules that could inhibit the opening of the FP with molecular docking of the FDA approved drug database (78) to 13 the seam presented between the FP and a kink in the HR1 helix (respectively in Site 1 Fig. 5 and S13). This site lays 14 above the rigid core β-sheet of CoVS (in this case the loop comprised of residues A1056-G1059), between the helical 15 part of the fusion peptide (residues I818-V826), the DR above the FP (residues 834-853), and the HR1 kink (residues 16 940-946). Twenty molecules with binding affinities ranging from -7 to -10 kcal/mol were identified (Table S1 ). In

To test the ability of asiaticoside to inhibit the FP opening, the same simulation methodologies were performed 

However, the current simulation methodology could only observe the initial steps in opening of the spike protein, 34 and many other steps are necessary for refolding during membrane fusion. We expect at least two other sites (Fig. 5,   35 see methods for details) could also provide hit compounds, further unlocking the possibility for drug cocktails with 36 binding to more than one site at a time. Blast alignment of the CoVS sequence demonstrate that these sites have low 37 mutability supporting their druggability (Fig. S1 ). To facilitate the search for such molecules, HTVS and ensemble 38 molecular docking were employed using 20 µs of simulation time provided for free to the scientific community from ligand-bound simulations for opening of these sites will require increases in simulation power and/or more targeted 3 enhanced sampling methodologies. However, based on the findings at the site near the FP (Fig. 4) , where the 4 formation of a few bridging interactions between adjacent domains resulted in a slowdown in fusion peptide opening, 5 it is likely that the ligands that form even more extensive bridging interactions at sites 2 and 3 could also restrict the 6 protein dynamics associated with membrane fusion.

Conclusion.

In summary, we investigated the dynamics of the SARS-COV-2 spike protein during the early stages of host-cell 10 infection with state-of-the-art enhanced sampling techniques. By using a of specific interchain distances that increase 11 during the FP opening of CoVS, we achieve rapid sampling of this process. This demonstrates a new way to select 12 the many initial structures required when using many short MD runs to explore configuration space(61), in that 

Perspectives towards antiviral 6 drug discovery against Ebola virus

Phylogenetic network analysis of SARS-CoV-2

Molecular modeling of the 7 effects of glycosylation on the structure and dynamics of human interferon-gamma

CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug 14 development

CHARMM general force field: A force field for drug-like molecules 17 compatible with the CHARMM all-atom additive biological force fields

Long-Time-Step Molecular Dynamics 19 through Hydrogen Mass Repartitioning

Accelerating Membrane Simulations with Hydrogen Mass Repartitioning

New Insights into the Folding of a β-Sheet 6

Miniprotein in a Reduced Space of Collective Hydrogen Bond Variables: Application to a Hydrodynamic 7 Analysis of the Folding Flow

Improvements in Markov State Model Construction Reveal Many 9

Non-Native Interactions in the Folding of NTL9

Order Parameters for Markov Model Construction

VAMPnets for Deep Learning of Molecular Kinetics

Variational Approach for Learning Markov Processes from Time Series Data

Everything You Wanted to Know about Markov State 17 Models but Were Afraid to Ask

Simulation of spontaneous G protein activation 19 reveals a new intermediate driving GDP unbinding

Estimation and uncertainty of reversible Markov 21 models

Brief report: New Variant Strain of SARS-CoV-2 7 Identified in Travelers from Brazil

Distinct Patterns of Emergence of SARS-CoV-2 Spike Variants including N501Y in Clinical

We thank Profs. Yvonne Janssen-Heininger and Jason Botten at UVM for helpful discussions. J. M. R., and K. T. M.

were supported by an NIH award (R01GM129431 to J. L.). J. L. and J. B. F. were partially supported by an NSF